[EN] 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [FR] DÉRIVÉ DE 7-NITRO-8-HYDROXYQUINOLÉINE, SON PROCÉDÉ DE PRÉPARATION ET UTILISATION MÉDICALE ASSOCIÉE [ZH] 7-硝基-8-羟基喹啉衍生物、其制备方法及其医药用途
[EN] 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [FR] DÉRIVÉ DE 7-NITRO-8-HYDROXYQUINOLÉINE, SON PROCÉDÉ DE PRÉPARATION ET UTILISATION MÉDICALE ASSOCIÉE [ZH] 7-硝基-8-羟基喹啉衍生物、其制备方法及其医药用途
Synthesis of Coordinatively Unsaturated Iridium Complexes Having Functional 8-Quinolinolato Ligands: New Catalysts for Dehydrogenative Oxidation of Alcohols in Aqueous Media
作者:Kazuki Toyomura、Ken-ichi Fujita
DOI:10.1246/cl.170166
日期:2017.6.5
these new complexes had coordinatively unsaturated structure (five-coordinate trivalent iridium: 16e− complex). Furthermore, one of the new complexes exhibited high catalytic activity for the dehydrogenative oxidation of various aromatic and aliphatic secondary alcohols in aqueous media to give the corresponding ketones in good to excellent yields.
A thiazolidine derivative represented by the formula (I)
1
wherein each symbol is as defined in the specification, and a pharmaceutically acceptable salt thereof exhibit a potent DPP-IV inhibitory activity, and can be provided as an agent for the prophylaxis or treatment of diabetes, an agent for the prophylaxis or treatment of obesity and the like.
THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF
申请人:SAKASHITA Hiroshi
公开号:US20070259880A1
公开(公告)日:2007-11-08
A thiazolidine derivative represented by the formula (I)
wherein each symbol is as defined in the specification, and a pharmaceutically acceptable salt thereof exhibit a potent DPP-IV inhibitory activity, and can be provided as an agent for the prophylaxis or treatment of diabetes, an agent for the prophylaxis or treatment of obesity and the like.
A thiazolidine derivative represented by the formula (I)
wherein each symbol is as defined in the specification, and a pharmaceutically acceptable salt thereof exhibit a potent DPP-IV inhibitory activity, and can be provided as an agent for the prophylaxis or treatment of diabetes, an agent for the prophylaxis or treatment of obesity and the like.